SEVEN EIGHT CAPITAL, LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$311,869
-71.3%
5,481
-80.0%
0.08%
-62.7%
Q3 2022$1,086,000
+90.9%
27,459
+112.3%
0.22%
-5.2%
Q2 2022$569,000
-10.1%
12,937
-16.9%
0.23%
+275.4%
Q3 2021$633,000
+213.4%
15,566
+228.5%
0.06%
+32.6%
Q1 2021$202,0000.0%4,7390.0%0.05%0.0%
Q4 2020$202,000
-36.7%
4,739
-61.0%
0.05%
-33.3%
Q3 2020$319,000
+45.0%
12,139
+48.1%
0.07%
-57.1%
Q2 2020$220,000
+3042.9%
8,196
+1539.2%
0.16%
+2583.3%
Q3 2015$7,000
+250.0%
500
+400.0%
0.01%
+200.0%
Q2 2015$2,0001000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders